48 assets in Gastric Carcinoma

Irinotecan

Binimetinib

Capivasertib

Crizotinib

Dabrafenib

Dasatinib

Defactinib

Fexagratinib

Gsk-2636771

Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide

Ipatasertib

Larotrectinib

Nivolumab

Osimertinib

Palbociclib

Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493

Pertuzumab

Relatlimab

Rivoceranib

Sapanisertib

Talazoparib

Trametinib

Trastuzumab

Trastuzumab Emtansine

Ulixertinib

Vismodegib

Adavosertib

Taselisib

Copanlisib

Adriamycin

Cis-Diamminedichloroplatinum Ii

Immunoglobulin G1 [351-Alanine,386-Alanine,387-Alanine] Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Imm2902 ?1-Chain), Disulfide With 1-125-Signal Regulatory Protein ? [80-Alanine] (Human Isoform 4 Variant) Fusion Protein With Peptide Linker ((Ggggs)3) Fusion Protein With Human-Mus Musculus Monoclonal Imm2902 ?-Chain, Dimer

xnw27011

Azenosertib

bi 765049

Ceralasertib

Elimusertib

Fludeoxyglucose

Fluorouracilum

Muamycin

nkt3447

nkt3964

Oxaliplatin

Trastuzumab Deruxtecan

89zr-dfo-n-suc-c9scfv

89Zr-DFO-N-Suc-F8scFv

Claudin18.2 Car-T Cells

Soluble Fluorescein